Get the Stockscreener App
2.305
0.66%
0.015
Kiora Pharmaceuticals Inc stock is traded at $2.305, with a volume of 22,680.
It is up +0.66% in the last 24 hours and down -14.63% over the past month.
Kiora Pharmaceuticals Inc is a clinical-stage biotechnology company developing and commercializing products for the treatment of orphan retinal diseases. As part of its development, KIO-301 is being studied for the treatment of retinitis pigmentosa, choroideremia, and Stargardt disease. It is a molecular photoswitch that has the potential to restore vision in patients with inherited and/or age-related retinal degeneration. KIO-104 is being developed for the treatment of posterior non-infectious uveitis. It is a next-generation, non-steroidal, immuno-modulatory, and small-molecule inhibitor of dihydroorotate dehydrogenase.
See More
Previous Close:
$2.29
Open:
$2.3
24h Volume:
22,680
Relative Volume:
0.46
Market Cap:
$7.91M
Revenue:
-
Net Income/Loss:
$2.81M
P/E Ratio:
-0.1606
EPS:
-14.3497
Net Cash Flow:
$7.14M
1W Performance:
-1.50%
1M Performance:
-14.63%
6M Performance:
-27.74%
1Y Performance:
-36.33%
1-Day Range:
$2.28
$2.34
1-Week Range:
$2.26
$2.3899
52-Week Range:
$2.21
$4.18
Kiora Pharmaceuticals Inc Stock (KPRX) Company Profile
Name
Kiora Pharmaceuticals Inc
Sector
Industry
Phone
858-224-9600
Address
169 SAXONY RD., ENCINITAS
Compare KPRX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
KPRX
Kiora Pharmaceuticals Inc
|
2.305 | 8.00M | 0 | 2.81M | 7.14M | -14.35 |
|
VRTX
Vertex Pharmaceuticals Inc
|
434.19 | 106.87B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
681.72 | 68.81B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.74 | 58.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
889.89 | 53.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
377.47 | 36.43B | 4.56B | -176.77M | 225.30M | -1.7177 |
Kiora Pharmaceuticals Inc Stock (KPRX) Latest News
How moving averages guide Kiora Pharmaceuticals Inc. tradingJuly 2025 PreEarnings & High Accuracy Investment Entry Signals - newser.com
Published on: 2025-11-12 21:15:50 - newser.com
Published on: 2025-11-12 16:48:17 - newser.com
Real time breakdown of Kiora Pharmaceuticals Inc. stock performanceTrend Reversal & Reliable Entry Point Trade Alerts - newser.com
Can Kiora Pharmaceuticals Inc. stock resist market sell offs2025 Institutional Moves & Daily Stock Momentum Reports - newser.com
Is Kiora Pharmaceuticals Inc. stock supported by strong cash flowsWeekly Risk Summary & Daily Oversold Stock Bounce Ideas - newser.com
Will Kiora Pharmaceuticals Inc. (7EY) stock beat Nasdaq index returnsWeekly Profit Recap & Daily Volume Surge Signals - newser.com
Chart based exit strategy for Kiora Pharmaceuticals Inc.2025 Market Sentiment & Weekly High Return Opportunities - newser.com
Heatmap analysis for Kiora Pharmaceuticals Inc. and competitorsGap Down & Free High Accuracy Swing Entry Alerts - newser.com
Published on: 2025-11-11 05:52:17 - newser.com
What candlestick patterns are forming on Kiora Pharmaceuticals Inc.Market Sentiment Summary & Risk Adjusted Buy/Sell Alerts - newser.com
Kiora Pharmaceuticals Reports Improved Financial Performance - TipRanks
Will Kiora Pharmaceuticals Inc. (7EY) stock benefit from commodity supercycle2025 Earnings Surprises & Trade Opportunity Analysis Reports - newser.com
Can Kiora Pharmaceuticals Inc. stock sustain free cash flow growthJuly 2025 Review & Weekly Breakout Watchlists - newser.com
News impact scoring models applied to Kiora Pharmaceuticals Inc.Quarterly Portfolio Summary & Long-Term Safe Investment Plans - newser.com
Intraday pattern recognizer results for Kiora Pharmaceuticals Inc.2025 Institutional Moves & Verified Swing Trading Watchlists - newser.com
Can Kiora Pharmaceuticals Inc. (7EY) stock attract ESG investmentsJuly 2025 Sentiment & Fast Gain Swing Alerts - newser.com
Analyzing recovery setups for Kiora Pharmaceuticals Inc. investorsMarket Trend Review & Risk Adjusted Buy and Sell Alerts - newser.com
KPRXKIORA PHARMACEUTICALS INC Latest Stock News & Market Updates - Stock Titan
Published on: 2025-11-07 09:17:23 - newser.com
Kiora Pharmaceuticals reports Q3 results, advances retinal disease trials By Investing.com - Investing.com Nigeria
Kiora Pharmaceuticals reports Q3 results, advances retinal disease trials - Investing.com India
Kiora Pharmaceuticals Inc reports results for the quarter ended September 30Earnings Summary - TradingView
[8-K] KIORA PHARMACEUTICALS INC Reports Material Event | KPRX SEC FilingForm 8-K - Stock Titan
[10-Q] KIORA PHARMACEUTICALS INC Quarterly Earnings Report | KPRX SEC FilingForm 10-Q - Stock Titan
Kiora (NASDAQ: KPRX) advances Phase II trials; $19.4M cash supports runway to late 2027 - Stock Titan
Kiora Pharmaceuticals (KPRX) Projected to Post Earnings on Friday - Defense World
Is it time to cut losses on Kiora Pharmaceuticals Inc.Entry Point & High Conviction Buy Zone Picks - newser.com
How buyback programs support Kiora Pharmaceuticals Inc. (7EY) stockPortfolio Risk Summary & Weekly Breakout Watchlists - newser.com
Will Kiora Pharmaceuticals Inc. continue its uptrendQuarterly Investment Review & Real-Time Market Sentiment Alerts - newser.com
Kiora Pharmaceuticals Inc Stock (KPRX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.62%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):